Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Breast Cancer Research and Treatment|February 4, 2022
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experienceAlicia Okines, Tazia Irfan, Bernice Asare, et al.Cardio-Oncology (London, England)|March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapyIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.Journal of Genetic Counseling|December 18, 2004
Initiation of reflective frames in counseling for Huntingtons Disease predictive testingSrikant Sarangi, Kristina Bennert, Lucy Howell, et al.Pediatrics|May 3, 2006
The safety of trivalent influenza vaccine among healthy children 6 to 24 months of ageMichael J Goodman, James D Nordin, Peter Harper, et al.Journal of Genetic Counseling|March 25, 2005
(Mis)alignments in counseling for Huntington's Disease predictive testing: clients' responses to reflective framesSrikant Sarangi, Kristina Bennert, Lucy Howell, et al.Advances in Therapy|March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.Cancer Treatment and Research Communications|July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experienceNicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.Drugs - Real World Outcomes|September 29, 2023
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical PracticeAlistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.Patient Preference and Adherence|January 26, 2019
Efficient development and usability testing of decision support interventions for older women with breast cancerKate J Lifford, Adrian Edwards, Maria Burton, et al.Therapeutic Advances in Medical Oncology|November 28, 2018
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paperNicolò Matteo Luca Battisti, Nienke De Glas, Mina S Sedrak, et al.Pageof 12